G
Guibin Li
Researcher at University of Kansas
Publications - 7
Citations - 716
Guibin Li is an academic researcher from University of Kansas. The author has contributed to research in topics: Cyclin-dependent kinase 5 & Calpain. The author has an hindex of 4, co-authored 4 publications receiving 678 citations.
Papers
More filters
Journal ArticleDOI
A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids.
Jose Antonio Chavez,Trina A. Knotts,Liping Wang,Guibin Li,Rick T. Dobrowsky,Gregory L. Florant,Scott A. Summers +6 more
TL;DR: It is demonstrated that exposing muscle cells to particular saturated free fatty acids, but not mono-unsaturated FFAs, inhibits insulin stimulation of Akt/protein kinase B, a serine/threonine kinase that is a central mediator of insulin-stimulated anabolic metabolism.
Journal ArticleDOI
Stabilization of the cyclin‐dependent kinase 5 activator, p35, by paclitaxel decreases β‐amyloid toxicity in cortical neurons
Guibin Li,Alexander A. Faibushevich,Brandon J. Turunen,Sung Ok Yoon,Gunda I. Georg,Mary L. Michaelis,Rick T. Dobrowsky +6 more
TL;DR: It is reported that paclitaxel (taxol) prevents cell death induced by Aβ peptides, inhibits Aβ‐induced activation of cyclin‐dependent kinase 5 (cdk5) and decreases tau hyperphosphorylation.
Journal ArticleDOI
Tau neurofibrillary pathology and microtubule stability.
TL;DR: The results suggest that drugs that interact with MTs can alter signaling events in neurons, possibly because some MTs play a role in organizing protein complexes involved in responses to Aβ.
Journal ArticleDOI
p35/Cyclin-dependent kinase 5 is required for protection against β-amyloid-induced cell death but not tau phosphorylation by ceramide
TL;DR: Ceramide inhibited Aß-induced calpain activation and cdk5 activity in wild-type neurons and protected against neuronal death and tau hyperphosphorylation, suggesting that ceramide can regulate Aß cell toxicity in a p35/cdk5-dependent manner.
Journal ArticleDOI
ACR Appropriateness Criteria® Osteoporosis and Bone Mineral Density: 2022 Update.
Joseph S. Yu,Nidhi G Krishna,Michael G. Fox,Donna G. Blankenbaker,Matthew A. Frick,Shari T. Jawetz,Guibin Li,Charles A. Reitman,Nicholas Said,J. Derek Stensby,Naveen Subhas,Mark Tulchinsky,Eric A. Walker,Francesca D. Beaman +13 more
TL;DR: The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel as discussed by the authors , which support the systematic analysis of the medical literature from peer reviewed journals.